Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2017
Michael Deininger, Ph.D., M.D. & Thomas O’Hare, Ph.D.
Targeting SIRT5 in acute myeloid leukemia
Read More
2017
Vered Stearns, M.D. & Roisin Connolly, M.D.
Harnessing the Immune System to Treat Breast Cancer
Read More
2016
Bradley Bernstein, M.D., Ph.D. and John Mullen, M.D.
Liposarcoma Genome Project
Read More
2016
Jessica Blackburn, Ph.D.
Single cell characterization and targeting of leukemia stem cells to prevent Acute...
Read More
2016
Anupriya Agarwal, M.S., Ph.D.
Critical role of microenvironment-driven interleukin-√ in AML disease progression and T cell...
Read More
2016
James Alvarez, Ph.D.
Targeting Dormant Cell Metabolism to Prevent Metastatic Recurrence
Read More
2016
Justin M. Balko, Pharm.D., Ph.D.
Maximizing neo-antigens in cancer by epigenetic modulation: improving responses to immunotherapy
Read More
2016
Raymond Blind, Ph.D.
Nuclear lipids as hepatocellular carcinoma biomarkers.
Read More
2016
Aniruddha Deshpande, Ph.D.
Identifying Novel Oncogenic Vulnerabilities in AML using Genome-scale Approaches
Read More
2016
Camila Dos Santos, Ph.D.
Characterizing the negative effects of pregnancy on myc-driven mammary tumors
Read More
2016
Michael Gatza, Ph.D.
An integrative genomic strategy to investigate oncogenic signaling in breast cancer
Read More
2016
Daniele Gilkes, Ph.D.
A novel hypoxia-induced fate marking strategy to determine how the hypoxic microenvironment...
Read More
2016
Gianna Hammer, Ph.D.
Microbiota induced upregulation of PDL1 on intestinal dendritic cells in intestinal tumorigenesis
Read More
2016
Mark Hatley, M.D., Ph.D.
Dissection of RAS pathway and PTEN loss in rhabdomyosarcoma
Read More
2016
Arminja Kettenbach, Ph.D.
Activity-based profiling of protein phosphatases in cancer
Read More
2016
Birgit Knoechel, M.D., Ph.D.
Differential enhancer engagement in drug resistant T-ALL and its therapeutic implications
Read More